Sumitomo Mitsui Financial is poised for growth with an improving NIM, a 10% profit boost by FY 2026. Click here to read why ...

Hello, everyone. Thank you for attending today's Blue Bird fiscal 2025 first quarter earnings conference call. My name is Sierra, and I will be your moderator for today. (Operator Instructions) I ...

With four months to go before a major decision, the Carlisle Area School Board is grappling with a shortfall of about $5.1 ...

The fragile state of NHS provider finances has often been well publicised, even if those finances have not made quite the same headlines in the past few years. As Sally Gainsbury and Sophie Julian ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

The massive dips on FARTCOIN and TRUMP signal the transfer of capital to new promising crypto projects. With almost $4 million raised in its presale, is FXGuys ($FXG) the new investment hotspot? Find ...

Dividend income is key to financial security in retirement. Check out my 4 dividend stock picks to help you reach your ...

Q4 2024 Earnings Call Transcript February 10, 2025 Harmonic Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $0.37. Operator: Welcome to the Fourth Quarter and Full Year 2024 ...

Fatorma's grassroots campaign was granted $1 million in U.S. funding in 2023 to continue work ... Stopping the work so suddenly has "a huge impact on actual human lives," Macher said.

Languages: English. Email: [email protected] As a result of President Donald Trump's freeze on foreign aid, a map of African countries shows where a drop in HIV funding from the U.S. could ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...